Mold in Hospitals: A Silent Threat to the Most Vulnerable Patients

Hospitals are supposed to be places of healing, but for immunocompromised patients, a hidden mold problem can transform a medical facility into a life-threatening environment. Unlike healthy individuals who can encounter mold spores with minimal consequence, patients receiving chemotherapy, organ transplant recipients, stem cell transplant patients, premature infants in the NICU, and others with severely compromised immune systems face catastrophic outcomes from fungal infection. When hospital infrastructure harbors mold — particularly in air handling systems, water-damaged ceiling tiles, or construction zones adjacent to patient care areas — the consequences can include invasive fungal infections with mortality rates that dwarf most other hospital-acquired pathogens.

This guide examines the primary hospital mold threat, the environments where mold risk is highest, the engineering controls and regulatory standards that govern healthcare facility mold prevention, documented outbreak patterns, and the rights of patients who find themselves hospitalized in a facility with a mold problem.

Aspergillus fumigatus: The Number-One Hospital Mold Threat

Aspergillus fumigatus is the primary mold species responsible for life-threatening fungal infections in hospitalized immunocompromised patients. This ubiquitous filamentous fungus produces conidia (spores) that are exceptionally small — 2–3 micrometers in diameter — allowing them to penetrate deep into the lung alveoli when inhaled. In a healthy immune system, alveolar macrophages neutralize A. fumigatus conidia before they can germinate and cause disease. In patients with profound neutropenia (absolute neutrophil count below 500 cells/mm³), high-dose corticosteroid therapy, or T-cell depletion from graft-versus-host disease treatment, this primary defense mechanism is absent.

Invasive pulmonary aspergillosis (IPA) begins when conidia germinate into hyphal forms that invade pulmonary blood vessels. Angioinvasion produces the pathognomonic “halo sign” on CT imaging — a ground-glass opacity surrounding a consolidation nodule reflecting hemorrhagic infarction around an infected vessel. If untreated or detected late, the infection disseminates hematogenously to the brain, kidneys, liver, and skin. Even with aggressive antifungal therapy using voriconazole or isavuconazole, mortality rates in this population are devastating.

The source of most hospital-acquired A. fumigatus infections is airborne spores from the outdoor environment or from construction and renovation activity within or adjacent to the hospital. Soil disturbance from excavation, demolition, and drywall work releases enormous bursts of fungal spores into the air. When these spores enter a hospital through inadequate dust barriers, unfiltered air supplies, or open windows and doors near construction zones, they can reach the rooms of neutropenic patients with lethal consequences.

Other clinically significant mold species in the hospital environment include Aspergillus flavus (sinusitis and skin infections in immunocompromised patients), Mucor and Rhizopus species causing mucormycosis (a rapidly progressive and often fatal angioinvasive infection), Fusarium species (disseminated infection in stem cell transplant recipients), and Scedosporium species (resistant to many antifungal agents). For more on individual mold species profiles, see our Aspergillus mold guide and Fusarium mold guide.

High-Risk Hospital Environments: Where Mold Hides

Mold does not distribute uniformly throughout a hospital. Certain environments carry dramatically higher contamination risk due to the combination of moisture, construction activity, air handling design, and patient population proximity.

Oncology and Bone Marrow Transplant Wards

Oncology and BMT (bone marrow transplant) wards house the highest-risk patients in any hospital: individuals undergoing cytotoxic chemotherapy, allogeneic hematopoietic stem cell transplant (allo-HSCT) recipients, and patients receiving immunosuppressive therapy for graft-versus-host disease. Minimum ventilation requirements for these areas call for positive-pressure rooms (to prevent contaminated corridor air from entering patient rooms), HEPA filtration of incoming air capable of removing particles >0.3 micrometers with 99.97% efficiency, and a minimum of 12 air changes per hour. Any failure in these engineering controls during construction or routine maintenance can create windows of exposure during which even brief high spore concentrations can prove fatal.

NICU and Pediatric ICU

Premature infants in the neonatal intensive care unit (NICU) have immature immune systems that cannot effectively clear fungal pathogens. Candida species are more common than molds in NICU fungal infections, but Aspergillus outbreaks in NICUs have been documented, typically associated with nearby construction or HVAC failures. Pediatric ICU patients on high-dose steroids for respiratory or inflammatory conditions also face elevated risk from Aspergillus and emerging mold pathogens.

Surgical Suites

Operating rooms require the highest air quality standards in the hospital: laminar airflow (unidirectional, high-velocity air flow that minimizes turbulence and particle accumulation over the surgical field), ultra-high-efficiency filtration, positive pressure, and frequent air changes (typically 20–25 per hour). Despite these controls, surgical site infections from mold have been documented, particularly in cases of compromised room air quality during renovation of adjacent spaces. Post-operative invasive aspergillosis in thoracic surgery or cardiac bypass patients is a particularly dreaded complication.

Construction and Renovation: The Primary Vector for Hospital Mold Outbreaks

The most consistent finding across documented hospital mold outbreaks is the role of construction and renovation activity as the triggering event. Hospitals are complex, living buildings that require constant maintenance and upgrade, but the intersection of construction activity and immunocompromised patient populations creates predictable and preventable risks.

The ICRA (Infection Control Risk Assessment) framework, developed in collaboration with the CDC and APIC (Association for Professionals in Infection Control and Epidemiology), provides a structured approach for evaluating and mitigating mold risk from hospital construction. ICRA requires risk stratification by the type of construction activity (from simple maintenance work to major demolition) and the vulnerability of adjacent patient populations (from office areas with no patient contact to areas housing the most immunocompromised patients). The intersection of these two variables determines the required infection control measures, which range from simple dust barriers to full HEPA-filtered negative-pressure enclosures with HEPA-equipped personnel entry/exit chambers.

Critical control measures during construction near high-risk patient areas include: sealed dust barriers with negative pressure maintained relative to the patient care environment; HEPA filtration of air exhausted from construction zones; wet methods for dust control; sealed ceiling penetrations and other architectural openings; dedicated construction personnel entry routes that do not pass through patient care areas; and regular air quality monitoring in adjacent patient spaces using settle plates, air sampling, or real-time particle counting. See our mold in commercial buildings guide and mold remediation certification guide for more on professional standards in complex environments.

HVAC Systems and Air Handling Units: Hidden Mold Infrastructure

A hospital HVAC system is both the primary defense against airborne mold contamination and, when compromised, a vehicle for distributing mold spores throughout an entire facility. HVAC-related mold in hospitals typically arises through several mechanisms: moisture accumulation in cooling coils, drain pans, and ductwork providing a substrate for mold growth; filter failure or bypass allowing spores to enter the distribution system; introduction of contaminated outside air during construction; and inadequate maintenance allowing biofilm accumulation in air handling units.

When mold colonizes an HVAC system serving multiple rooms or an entire wing, the outbreak potential is far greater than localized surface mold. A contaminated air handling unit can simultaneously expose hundreds of patients to elevated spore levels. This is why HVAC system maintenance is explicitly addressed in CDC and ASHRAE standards for healthcare facilities, including requirements for regular filter inspection and replacement, coil and drain pan cleaning, and duct inspection on defined schedules. See our guide on mold in HVAC ductwork for detailed information on detection and remediation of HVAC mold contamination.

CDC and Joint Commission Standards for Healthcare Facility Mold Control

Regulatory and accreditation standards for healthcare facility mold control are primarily defined by the CDC, The Joint Commission (TJC), and by reference to engineering standards from ASHRAE, ANSI, and the FGI (Facility Guidelines Institute). Understanding these standards is essential for healthcare facility infection control practitioners, facility managers, and patient advocates.

CDC Guidance

The CDC’s guidelines for environmental infection control in healthcare facilities (2003, updated periodically) provide the foundational framework for hospital mold prevention. Key provisions address: HVAC design and maintenance standards for different hospital functional areas; specific air quality requirements for high-risk patient areas (protected environments); infection control precautions during construction and renovation; and response protocols when environmental mold sampling detects elevated counts. The CDC also publishes specific guidance on preventing healthcare-associated infections with filamentous fungi (molds) in immunocompromised patient populations.

Joint Commission Environment of Care Standards

The Joint Commission accreditation process includes Environment of Care (EC) standards that require hospitals to: proactively identify environmental hazards including water intrusion and mold; maintain an active infection control surveillance program that includes environmental monitoring; conduct ICRA for construction and renovation projects; and respond appropriately when environmental hazards are identified. Failure to maintain adequate mold prevention measures can result in citations, directed improvement plans, and in severe cases, loss of accreditation. For healthcare facilities in the mold remediation process, see our mold remediation process guide and certification guide.

ASHRAE 170-2021: Ventilation of Health Care Facilities

ASHRAE Standard 170 is the primary engineering standard governing air quality in healthcare facilities. It specifies minimum and maximum ventilation rates, pressure relationships, filtration efficiency, temperature and humidity ranges, and air distribution design for every functional area of a healthcare facility. The standard has been incorporated by reference into the FGI Guidelines for Design and Construction of Hospitals and into most state healthcare facility licensing regulations, making it effectively legally binding in most U.S. jurisdictions.

Documented Hospital Mold Outbreaks: Lessons from the Literature

Hospital mold outbreaks are not rare historical curiosities — they have been documented repeatedly in the peer-reviewed medical literature and at major academic medical centers. Understanding the patterns of documented outbreaks illuminates both the risk factors and the prevention strategies that can interrupt them.

Perhaps the most instructive cluster outbreaks have involved construction-associated aspergillosis in transplant units. In a widely cited series from a major U.S. academic center, a cluster of invasive aspergillosis cases in an allo-HSCT unit was traced to demolition work in an adjacent laboratory space. Investigation revealed that dust barriers between the construction zone and the patient care area were inadequately sealed, allowing spore-laden air to migrate through unsealed ceiling penetrations into the air handling system serving the transplant unit. Multiple patients developed IPA during the outbreak period, several fatally. The outbreak was terminated when construction was halted, barriers were properly resealed, and HEPA filtration was added to the patient care area air supply.

Outbreaks associated with water damage are equally well-documented. A single water intrusion event — a roof leak, a burst pipe, flooding from a floor above — that saturates ceiling tiles, drywall, or insulation in proximity to immunocompromised patient areas can trigger mold growth within 24–48 hours. When remediation is delayed or inadequate, the resulting mold reservoir can produce ongoing sporulation and elevated airborne counts that persist for months. For information on mold after water damage events, see our mold after water damage guide.

Mucormycosis outbreaks, while less common than aspergillosis outbreaks, have been associated with contaminated medical supply materials including contaminated ostomy bags, tongue depressors, and bandage materials. These outbreaks highlight that the mold threat in hospitals extends beyond the air supply to include any material that can harbor fungal spores. For more on mold species found in healthcare settings, see our Mucor mold guide.

Hospital Mold Risk Areas: Comparison Table

The table below compares the seven highest-risk mold environments in hospitals, including the required control measures, regulatory standards, outbreak indicators, and response protocols for each area.

Patient Rights When Hospitalized in a Moldy Facility

Patients who discover or suspect mold in a hospital have specific rights and avenues for addressing the issue. Understanding these rights is important for patient advocates, family members, and healthcare workers who identify mold problems.

Right to a Safe Environment

Under the Medicare Conditions of Participation (CoPs), hospitals receiving Medicare and Medicaid funding are required to maintain a safe, sanitary physical environment. Environmental hazards including mold that create risk for patients are violations of these CoPs. Patients or family members who identify mold problems can report concerns to the hospital’s infection control department, patient safety officer, or risk management team.

Joint Commission Complaint Process

If internal hospital channels are unresponsive, patients and family members can file complaints directly with The Joint Commission through its complaint hotline or online portal. The Joint Commission investigates complaints about safety and quality issues at accredited facilities. A substantiated mold complaint can trigger an unannounced survey and required corrective action plan.

State Health Department Reporting

State departments of health license and inspect healthcare facilities and have authority to investigate environmental hazards including mold. Patients, family members, or staff can report mold concerns to the state health department, which may conduct an inspection and require remediation as a condition of continued licensure.

CMS Reporting

The Centers for Medicare and Medicaid Services (CMS) accepts complaints about Medicare and Medicaid-certified facilities through its 1-800-MEDICARE hotline and online complaint system. CMS can direct state survey agencies to inspect facilities and can impose sanctions including civil monetary penalties, directed improvement plans, and termination of Medicare participation for unresolved safety violations.

Right to Transfer

Patients in acute care settings have the right to request transfer to another facility, and hospitals are required to facilitate safe transfer when requested and medically appropriate. For immunocompromised patients facing documented mold risk, transfer to a facility with adequate protective environment infrastructure may be the most appropriate response. Physicians and case managers can assist in arranging transfer when the current facility environment poses unacceptable risk.

For guidance on mold disclosure requirements in other settings, see our mold disclosure laws guide and our resource on tenant rights regarding mold.

Prevention: Engineering Controls, Surveillance, and Response Protocols

Preventing mold-related infections in hospitalized patients requires a layered approach combining engineering controls, active surveillance, staff education, and clear response protocols.

Engineering Controls: The First Line of Defense

Primary engineering controls include: HEPA filtration of supply air to protected environments; positive pressure rooms for immunocompromised patients; adequate air change rates (12+ for protective environments, 20+ for operating rooms); tight building envelope maintenance preventing outdoor spore infiltration; proactive identification and rapid repair of water intrusion events; and ICRA implementation for all construction and renovation activity.

Environmental Surveillance

Active environmental surveillance for airborne mold includes regular settle plate cultures in high-risk areas, periodic air volumetric sampling using devices such as the RCS Plus or Andersen sampler, and real-time particle counting systems that provide continuous monitoring with alarm notification when particle counts exceed thresholds. Surveillance programs should be designed with infectious disease and infection control input, and results should be reviewed regularly with clinical leadership.

Antifungal Prophylaxis for Highest-Risk Patients

In addition to environmental controls, clinical prophylaxis with antifungal agents (most commonly posaconazole or voriconazole) is standard of care for allo-HSCT recipients and high-risk AML patients during neutropenia. Prophylaxis does not substitute for environmental controls but provides an additional layer of protection during the highest-risk period. The interaction between environmental control failures and inadequate prophylaxis — particularly in centers where antifungal prophylaxis is inconsistently applied — accounts for many preventable outbreak-related deaths.

For more on mold-related immune compromise, see our guides on how mold suppresses the immune system and mold and cancer patients.

Frequently Asked Questions

What is the mortality rate from hospital-acquired invasive aspergillosis?

Mortality from invasive aspergillosis in immunocompromised hospital patients ranges from 30–95% depending on the patient population. In allogeneic stem cell transplant recipients, mortality often exceeds 80% when diagnosis is delayed beyond 72 hours. In patients with less severe immunosuppression (such as those on moderate doses of corticosteroids), outcomes are somewhat better with early treatment, but the infection remains life-threatening. Early diagnosis using galactomannan antigen testing, CT imaging with halo sign assessment, and bronchoscopy with culture is essential for improving outcomes.

How does hospital construction cause mold infections in patients?

Construction and demolition activity disturbs soil and building materials that harbor Aspergillus and other mold spores. When dust barriers are inadequate, poorly sealed, or breached, spore-laden air migrates from the construction zone into adjacent patient care areas. If this migration reaches areas housing neutropenic or otherwise immunocompromised patients, even brief exposure to elevated spore concentrations can trigger invasive infection. Approximately 70% of documented hospital mold outbreaks are associated with nearby construction activity.

What is HEPA filtration and why is it required for immunocompromised patient areas?

HEPA (High-Efficiency Particulate Air) filtration uses fiber mat filters that capture 99.97% of airborne particles at 0.3 micrometers in diameter — the most penetrating particle size. Since A. fumigatus conidia are 2–3 micrometers in diameter, HEPA filtration removes them from incoming air with near-complete efficiency. Positive-pressure HEPA-filtered rooms maintain higher air pressure than adjacent corridors, ensuring that air flows outward (from clean room to corridor) rather than inward, preventing corridor air from entering the protected patient environment.

What should I do if I notice mold in a hospital room?

If you or a family member notices visible mold, musty odors, water-stained ceiling tiles, or other signs of mold in a hospital room — particularly if the patient is immunocompromised — immediately notify the nursing staff and request to speak with the infection control practitioner. Document the observation with photographs. If the hospital does not respond appropriately, escalate to The Joint Commission, the state department of health, or CMS. See our mold illness symptoms guide for information on recognizing potential mold-related health effects.

Can mold from a hospital stay cause long-term health problems?

In immunocompromised patients, hospital-acquired invasive aspergillosis or other mold infections can cause permanent organ damage including pulmonary cavities, neurological injury from CNS invasion, and reduced lung function. In patients who survive disseminated infection, the sequelae can be significant and lasting. For immunocompetent patients, brief mold exposure during hospitalization is unlikely to cause serious illness, though it may trigger allergic responses in sensitized individuals. See our mold and immune system guide for more information.